| 000 | 01770 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516223712.0 | ||
| 264 | 0 | _c20150330 | |
| 008 | 201503s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2014.07.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarzon, Luisa | |
| 245 | 0 | 0 |
_aNeutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes. _h[electronic resource] |
| 260 |
_bVaccine _cSep 2014 |
||
| 300 |
_a5357-62 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Neutralizing _xblood |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 |
| 650 | 0 | 4 | _aHuman papillomavirus 16 |
| 650 | 0 | 4 | _aHuman papillomavirus 18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Programs |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xprevention & control |
| 650 | 0 | 4 |
_aPapillomavirus Vaccines _xtherapeutic use |
| 700 | 1 | _aSquarzon, Laura | |
| 700 | 1 | _aMasiero, Serena | |
| 700 | 1 | _aPacenti, Monia | |
| 700 | 1 | _aMarcati, Giorgia | |
| 700 | 1 | _aMantelli, Barbara | |
| 700 | 1 | _aGabrielli, Liliana | |
| 700 | 1 | _aPascucci, Maria Grazia | |
| 700 | 1 | _aLazzarotto, Tiziana | |
| 700 | 1 | _aCaputo, Antonella | |
| 700 | 1 | _aPalù, Giorgio | |
| 773 | 0 |
_tVaccine _gvol. 32 _gno. 41 _gp. 5357-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2014.07.014 _zAvailable from publisher's website |
| 999 |
_c24027276 _d24027276 |
||